Literature DB >> 8467561

Augmentation by transferrin of IL-2-inducible killer activity and perforin production of human CD8+ T cells.

A Nakamura1, S Sone, R Nabioullin, K Sugihara, M Munekata, Y Nishioka, A Nii, T Ogura.   

Abstract

The effects of human transferrin (Tf) on lymphokine (IL-2)-activated killer (LAK) induction from blood lymphocytes of healthy donors was examined. LAK cells were induced by 6-day incubation in medium with recombinant human IL-2 of lymphocytes, and their cytotoxic activity was assessed by measuring 51Cr release from NK-resistant Daudi cells. Tf alone did not induce any LAK activity, but in combination with IL-2, it augmented LAK induction dose- and time-dependently. This augmenting effect was completely abolished by pretreatment with anti-Tf antiserum. Tf augmented the proliferative response of lymphocytes to IL-2 and their expressions of receptors for IL-2 and Tf. CD8+ T cells were isolated from purified blood lymphocytes using antibody-bound magnetic beads. Addition of Tf to cultures of CD8+ cells resulted in significant augmentation of killer cell induction and perforin (PFP) production after 4 days stimulation with IL-2. These results indicate that Tf is important in generation of IL-2-inducible killer properties and PFP activity of human CD8+ T cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8467561      PMCID: PMC1554887          DOI: 10.1111/j.1365-2249.1993.tb05966.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  33 in total

1.  Generation of lymphokine-activated killer activity in T cells. Possible regulatory circuits.

Authors:  R L Geller; M J Smyth; S L Strobl; F H Bach; F W Ruscetti; D L Longo; A C Ochoa
Journal:  J Immunol       Date:  1991-05-15       Impact factor: 5.422

Review 2.  Perforin-mediated target cell lysis by cytolytic T lymphocytes.

Authors:  J Tschopp; M Nabholz
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Monocyte-dependent, serum-borne suppressor of induction of lymphokine-activated killer cells in lymphocytes from melanoma patients.

Authors:  K Itoh; N R Pellis; C M Balch
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

4.  Humoral modulation of lymphokine-activated killer (LAK)-cell induction in humans: IgG-related and non-IgG inhibitors in sera from cancer patients.

Authors:  L B Riley; N R Pellis; S P Schantz; R S Freedman; C M Balch; K Itoh
Journal:  Int J Cancer       Date:  1990-11-15       Impact factor: 7.396

5.  Induction of protein kinase C mRNA in cultured lymphoblastoid T cells by iron-transferrin but not by soluble iron.

Authors:  O Alcantara; M Javors; D H Boldt
Journal:  Blood       Date:  1991-03-15       Impact factor: 22.113

6.  IL-2 and IL-6 synergize to augment the pore-forming protein gene expression and cytotoxic potential of human peripheral blood T cells.

Authors:  M J Smyth; J R Ortaldo; W Bere; H Yagita; K Okumura; H A Young
Journal:  J Immunol       Date:  1990-08-15       Impact factor: 5.422

7.  Up-regulation by granulocyte-macrophage colony-stimulating factor (GM-CSF) of induction of lymphokine (IL-2)-activated killer (LAK) cells by human blood monocytes.

Authors:  S M Singh; S Sone; N Inamura; T Ogura
Journal:  Int J Cancer       Date:  1989-07-15       Impact factor: 7.396

8.  Thy-1-positive dendritic epidermal cells contain a killer protein perforin.

Authors:  T Kobata; Y Shinkai; Y Iigo; A Kawasaki; H Yagita; S Ito; S Shimada; S I Katz; K Okumura
Journal:  Int Immunol       Date:  1990       Impact factor: 4.823

9.  Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells.

Authors:  M J Smyth; J R Ortaldo; Y Shinkai; H Yagita; M Nakata; K Okumura; H A Young
Journal:  J Exp Med       Date:  1990-04-01       Impact factor: 14.307

10.  Interleukin-2-inducible killer activity and its regulation by blood monocytes from autologous lymphocytes of lung cancer patients.

Authors:  S Sone; E Kunishige; F Fawzy; H Yanagawa; A Nii; K Maeda; S Atagi; Y Heike; Y Nishioka; K Mizuno
Journal:  Jpn J Cancer Res       Date:  1991-06
View more
  1 in total

Review 1.  The major histocompatibility complex-encoded HFE in iron homeostasis and immune function.

Authors:  L Salter-Cid; P A Peterson; Y Yang
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.